93879-55-1

Upstream product

• 156-43-4 4-Ethoxyaniline 
• 19165-26-5 2-(propionylamino)benzoic acid 
• 118-92-3 anthranilic acid 

Downstream Products

• 876016-38-5 2-(1-bromo-ethyl)-3-(4-ethoxy-phenyl)-3H-quinazolin-4-one 
• 947536-71-2 3-(4-ethoxy-phenyl)-2-{1-[(pyridin-3-ylmethyl)-amino]-ethyl}-3H-quinazolin-4-one 
• 947535-98-0 2-[1-(2-dimethylamino-ethylamino)-ethyl]-3-(4-ethoxy-phenyl)-3H-quinazolin-4-one 

Relevant academic research and scientific papers

Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists

CXC chemokine receptor-3 (CXCR3) is a G-protein coupled receptor (GPCR) predominantly expressed on activated T lymphocytes that promote Th1 responses. Previously, we described the 3H-quinazolin-4-one containing VUF 5834 (decanoic acid {1-[3-(4-cyano-pheny

Pyrimidinone compounds

This invention relates to treating inflammatory and immune diseases with certain pyrimidinone compounds that bind to CXCR3 receptors. The pyrimidinone compounds are covered by the formula (I) shown below. Each variable is defined in the specification.